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Abstract Together with vitamin C, zinc, selenium, manga-
nese, and magnesium play a vital role in the preservation of
organs scheduled for transplantation. In the present study, it
is shown that addition of 1 mg/l of these elements influences
the stability of 0.3 mM ascorbic acid solutions. The solu-
tion’s stability was estimated using an accelerated stability
test. The concentration of vitamin C was measured using a
validated spectrophotometric method, which uses the reduc-
tion of 2,6-dichlorophenoloindophenol by ascorbic acid.
Elevated temperatures, the factor accelerating substances’
decomposition reaction rate, were used in the tests. The
research was conducted at two temperatures at intervals of
10 °C: 80±0.1 and 90±0.1 °C. It was stated that the studied
substances’ decomposition occurred in accordance with the
equation for first-order reactions. The function of the loga-
rithmic concentration (log%C) over time was revealed to be
rectilinear. This dependence was used to determine the
kinetics of decomposition reaction rate parameters. The
stabilization of vitamin C solutions was measured as the
time in which 10 % of the substance decomposed at 20 and
0 °C. Addition of Se(IV) or Mg(II) ions significantly increase
the stability of ascorbic acid solution (∼34 and ∼16 %, respec-
tively), but Zn(II) causes a significant decrease in stability by
∼23 %. Addition of Mn(II) has no significant influence on
vitamin C stability.
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Introduction
Trace elements are essential for appropriate function of
living organisms. Some elements can have a protective
influence on selected organs during ischemia and reperfu-
sion [1–6] and might have a positive role in stabilization of
organ preservation solutions [7–9]. One such element is
selenium, a component of glutathione peroxidase that plays
a protective role against the oxidizing action of hydrogen
peroxide [1–4].
Zinc influences cell membrane structure and function. It is a
component of several enzymes and stimulates protein synthe-
sis. It is a component of superoxide dismutase (Cu/Zn-SOD)
and takes part in quenching of superoxide radicals. It was
concluded that zinc is a HSP70 protein activator, which pro-
tects the liver during preservation [5].
Manganese is located at the active site of superoxide
dismutase (Mn-SOD), which also eliminates superoxide
anion radical. Increased activity of Mn-SOD is observed as
a result of osmotic shock and action of reagents generating
the anion radical [6]. Magnesium compounds are found in
preservation solutions: ViaSpan, histidine–ketoglutarate–
tryptophan (HTK), Celsior, Perfadex, Plegisol, and Polysol
[7, 10, 11].
Preservation and perfusion solutions are enriched with
anti-oxidizing agents, such as vitamin C. It helps protecting
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organs against ischemia–reperfusion damage, especially
oxidative stress [10–13]. Vitamin C administration in
rabbits during kidney transplantation reduces the effects
of lipid peroxidation and improves performance of the
graft [13]. Ascorbic acid used at 0.3 mM concentration
is the most efficient antioxidant for HTK, Celsior, and
ViaSpan solutions [14–17]. Solid vitamin C is relatively
stable, but it decomposes rather quickly when dissolved in
water. Factors such as pH, temperature, oxygen, and the
presence of catalysts (iron, copper) influence the decom-
position process. The lowest rate of oxidation is observed
at pH 3, where vitamin C solutions are the most stable.
Raising the pH to 5 increases the oxidation rate by a
factor of 2. Preservation solutions need to mimic the physio-
logical pH of serum (7.35–7.45), pH at which vitamin C is
unstable.
For these reasons, we decided to study the stabiliza-
tion effect of adding Zn(II), Se(IV), Mn(II), or Mg(II) at
a concentration of 1 mg/l to 0.3 mM ascorbic acid, for
use in preservation solutions for organs used in trans-
plants. The time at which 10 % of the ascorbic acid is
degraded at 20 °C was used as a measure of stabiliza-
tion efficiency. Based on decomposition kinetics, a lin-
ear dependence between degradation speed and temperature
was established.
Materials and Methods
Characteristics of Used Substances
L(+)-Ascorbic acid C6H8O6, mol. wt.0176.13 g/mol; man-
ganese sulfate [MnSO4·5H2O], mol. wt.0241.07 g/mol; and
zinc acetate [Zn(CH3COO)2], mol. wt.0219.49 g/mol were
purchased from POCh Gliwice, Poland. Sodium selenite
[Na2SeO3], mol. wt.0172.94 g/mol, was obtained from
Sigma-Aldrich, Poland. Magnesium fumarate [C4H2MgO4],
mol. wt.0138.38 g/mol, was purchased from F.Z.N.P. “Bio-
chefa.” All the reagents were analytically pure and met all
necessary regulations.
Solutions
Ascorbic acid stock solutions (0.3 mM) were produced
using pro injectione-grade water. The selected stabilizing
agents were added at 1 mg/l to the stock solution to
produce the Zn(II), Se(IV), Mn(II), or Mg(II) study sol-
utions. All solutions were prepared under Good Manufac-
turing Practice conditions in a laminar flow unit, filtered
using a 0.22-μm Sartopure GF 2 cellulose acetate filter at
a 50-ml/min flow rate. The solutions were stored in 10 ml
hydrolytic class 1 glass vials, secured with rubber stoppers
and aluminum caps.
Measurement of the Vitamin C Concentration
The concentration of vitamin C was measured using a
validated spectrophotometric method, which uses the reduc-
tion of 2,6-dichlorophenoloindophenol by ascorbic acid. A
1-mg/ml ascorbic acid solution in 2.5 % metaphosphoric
acid was used as stock solution to construct a calibration
curve in the 30 to 250 μg/ml range. The absorbance was
read at 520 nm in 1.0-cm glass cuvettes using a CE 3021
UV–VIS Spectrophotometer (Cecil, England). The vitamin C
concentration was calculated using an extinction coefficient
ε05.17·104·l·M−1cm−1. The curve was fitted by the linear
regression equation: y0−0.0244x+0.6778 (R200.9995; linear
regression error, 0.00012).
Solutions Stability Analysis Using Accelerated Stability
Test
The accelerated stability test [14–18] was used to estimate
the stability of vitamin C solutions based on the kinetics of
the reaction rate of ascorbic acid concentration change at
elevated temperatures. Vials were tested for tightness by
immersing in 1 % methylene blue solution. Ten vials con-
taining 0.3 mM ascorbic acid with or without the selected
tested ions were placed in a water ultra thermostat (U7,
temperature test precision ±0.1 °C). The test was run at
two different temperatures: 80 °C (353 K) and 90 °C
(363 K). These temperatures were chosen based on prior
studies of ascorbic acid decomposition rate.
Samples were taken when temperature of the tested so-
lution reached the desired temperature at 0 (100 % ascorbic
acid), 1, 2, 3, 4, 6, and 8 h from the starting point of the
experiment. Collected samples were cooled in water with
ice directly after sampling in order to halt further decompo-
sition of the substance. It was stated that the studied sub-
stances’ decomposition occurred in accordance with the
equation for first-order reactions. The function of the loga-
rithmic concentration (log%C) over time was revealed to be
rectilinear. This dependence was used to determine the
kinetics of decomposition reaction rate parameters. Based
on the obtained data, the following were calculated: the
decomposition reaction rate constants of ascorbic acid (k)
at the temperature of 80 and 90 °C, temperature factor Q10,
the decomposition rate constant of ascorbic acid at the
temperature of 20 and 0 °C, and the stability at the temper-
ature of 20 and 0 °C (t10%). The stability (t10%) is the time
period after which ascorbic acid concentration decreases by
10 % in the solution. The decrease in ascorbic acid concen-
tration by 10 % was calculated with the formula:
t10% ¼ 0:1053
kð20 CÞ
and 10% ¼ 0:1053
kð0 CÞ
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The decomposition rate constants of ascorbic acid (k)






Where C0 is the concentration at t00 and Cx at any given
time t.
The dependence of reaction rate on temperature is char-




The solution stability at the temperature of 20 and 0 °C
was calculated using the formula:
k20 C ¼ k80
C
Q6




The results are presented as a mean value (x) and standard
deviation calculated from 10 samples. The decomposition of
ascorbic acid added with 1 mg/l Zn(II), Se(IV), Mn(II), or Mg
(II) was compared to the decomposition of untreated control
solution. The statistical significance was established at p<0.05
using Student’s t test. Using variance analysis, we calculated
the significance of microelements on ascorbic acid solution
stabilization. All calculations were performed using Microsoft
Excel and Statistica for Windows 5.1 software.
Results
Preservation and perfusion solutions are a transient environ-
ment for organs used for transplantation. Consequently, the
effectiveness and stability of the solution are crucial for
safety of the transplant patients.
The degradation of aqueous solutions of ascorbic acid
occurred at various rates depending on the trace element
added. The slowest degradation was observed for Se(IV)
and the fastest for Zn(II) ions. Table 1 shows the parameters
describing the kinetics of ascorbic acid degradation in the
study and control solutions. Analysis of variance has shown
significant influence of added microelements on the stabiliza-
tion of ascorbic acid solution (F(4,10)0247,61; p<0.0000).
As a result of the antioxidant properties of Se(IV), its
addition to 0.3 mM ascorbic acid significantly increases the
stability of the solution from ∼95 to ∼127 days, which is
about 34 % over the stability of the control solution. Adding
magnesium fumarate increased the stability of ascorbic acid
solutions significantly, by ∼16 % to ∼110 days.
In the presence of Zn(II) ions, the stability of ascorbic
acid significantly decreased by ∼23 % (∼73 days). This is
probably a result of a catalytic action of Zn(II) ions on
ascorbate oxidation. Addition of Mn(II) had no significant
effects on the stability of ascorbic acid.
Discussion
Preservation and perfusion solutions must be water-based.
Free protons and hydroxide anions that might be present in
aqueous solutions have the potential to generate free radi-
cals. As a strong polar solvent, water is an ideal environment
favoring decomposition reactions that decrease solution sta-
bility and effectiveness. Addition of suitable antioxidants is
therefore crucial for maintaining the stability of solutions
that will be used in preservation of transplant organs.
Adding Se(IV) to 0.3 mM ascorbic acid solution signif-
icantly increases its stability. Additionally, selenium ions
can play a vital role in minimizing ischemia–reperfusion
damage in kidneys during perfusion, preservation, and
Table 1 Parameters describing the kinetics of ascorbic acid degradation in the study and control solutions (means±standard error)
Stability
parameters
0.3 mM vit. C (control) 0.3 mM vit. C + Zn(II) 0.3 mM vit. C + Se(IV) 0.3 mM vit. C + Mn(II) 0.3 mM vit. C + Mg(II)
C90°C (%) 51.14±0.15 52.44±0.73 60.43±2.31* 51.14±0.71 56.74±1.82*
C80°C (%) 76.44±1.32 79.36±1.43* 83.88±1.52* 79.44±1.11* 82.06±1.15*
k90°C (h
−1) 0.082±0.002 0.080±0.002 0.062±0.003 0.082±0.001 0.070±0.002
k80°C (h
−1) 0.035±0.001 0.027±0.005 0.021±0.004 0.035±0.003 0.024±0.003
t10 % 20 °C(days) 94.98±0.74 73.09±1.07* 127.45±1.92* 94.98±0.93 110.44±1.50*
t10 % 0 °C (years) 2.20±0.02 1.57±0.04* 2.97±0.07* 2.19±0.03 2.56±0.04*
C90 °C (%) vit. C content after accelerated aging test at 90 °C, C80 °C (%) vit. C content after accelerated aging test at 80 °C, k90 °C (h
−1 ) vit. C
decomposition constant at 90 °C, k80 °C (h
−1 ) vit. C decomposition constant at 80 °C, t10 % 20 °C (days) vit. C stability at 20 °C, t10 % 0 °C (years) vit.
C stability at 0 °C
*p<0.05, statistically significant in comparison to controls—vit. C solution with no microelement added
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reperfusion. It was concluded that addition of selenium to
preservation solutions protects kidneys against oxidative
stress during ischemia [1]. A decrease in the concentration
of malondialdehyde was seen 2 h after kidney transplanta-
tion as a result of adding selenium to HTK solution [2].
Selenium addition to Euro-Collins (EC) solution proved
higher efficiency in lung protection during ischemia–reper-
fusion than the original EC solution [3]. Addition of sodium
selenite to a preservation solution at an optimal concentra-
tion of 0.5 μM positively influences heart function after
warm ischemia [4].
Magnesium ions also cause increase in vitamin C stabil-
ity. It was also proved that magnesium ions stabilize cell
membranes and activate enzymes responsible for synthesis,
storage, and assimilation of high-energy compounds. Mag-
nesium ions Mg(II) were added in the form of fumarate
because fumarate shows positive influence in cardioplegia
solutions. It helps myocardial contractility because it causes
a decrease of lactic dehydrogenase, which increases with the
number of dead cells [19].
Ascorbate can act as a monodentate ligand that reacts
with metal cations in aqueous solutions resulting in low
stability water-soluble complexes. This complexation reac-
tion involves the lactone ring and the side chain [20]. By
decreasing the amount of free cations, precipitation does not
occur, increasing the stability of the solutions.
Addition of Se(IV) and Mg(II) ions to 0.3 mM ascorbic
acid solutions significantly increases its stability but Zn(II)
decreases it. The addition of Mn(II) has no significant in-
fluence on the stability of ascorbic acid.
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